A Clinical Practice Snapshot on Pediatric Kidney Transplantation

Kidney Transplant Failure Clinical Trial

Official title:

A Clinical Practice Snapshot on Pediatric Kidney Transplantation Healthcare in Europe

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05619679
• Other study ID #: PKT.Clinical.Snapshot
• Status: Completed
• Start date: January 10, 2022
• Est. completion date: June 30, 2023

Study information

• Verified date: November 2023
• Source: Radboud University Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim is to create an overview of the similarities and differences in daily practice among the different centers performing pediatric kidney transplantation in Europe.

For this purpose, a Clinical Practice Snapshot will be used to provide insight in the current approaches.

Description:

In order to create an overview of the current care for pediatric kidney transplant (PKT) recipients a clinical practice snapshot was developed.

All participating centers were asked to answer 6 clinical questions on their last 30 transplanted patients.

Patient characteristics, donor charactertistics, use of stents, immunosuppressive medication and renal function are compared between centers.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 410
• Est. completion date: June 30, 2023
• Est. primary completion date: June 30, 2023
• Gender: All
• Age group: 0 Years to 18 Years

Eligibility

Inclusion Criteria:

• Kidney received <18 years

• at least one month of follow-up

• transplantation and follow-up in dedicated PKT center

Exclusion Criteria:

• combined transplantation

Related Conditions & MeSH terms

• Kidney Transplant Failure

Intervention

Other:
• Kidney Transplantation
Kidney transplantation

Locations

Country	Name	City	State
Netherlands	Radboud University Medical Center	Nijmegen

Sponsors (1)

Lead Sponsor	Collaborator
Radboud University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Graft survival	Functioning graft	at end of follow-up at least one month
Primary	Donor type	Living or deceased donor	At transplantation
Secondary	Immunosuppressants prescribed at discharge	Immunosuppressive medication at discharge after transplant	2 weeks
Secondary	Number of infections	Viral infections after transplantations	end of follow-up, at least one month